Paid Clinical Trials in Alabama

Alabama has 1,279 paid clinical trials enrolling now across cities including Birmingham, Mobile and Huntsville. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 29, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1,110 clinical trials

↓ Download CSV

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis

for Palmoplantar Pustulosis

Drug: Bimekizumab

Sites in Birmingham +5 more locations

Sponsor: UCB Biopharma SRL

Sex: All·Age: 18+

Code: NCT07219420·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD)

for Alcohol Use Disorder

Sites in Tuscaloosa +7 more locations

Sponsor: Brainsway

Sex: All·Age: 18 - 86

Code: NCT07216872·Recruiting·Listed Oct 2025

Apply to this trial

Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy

for Invasive Mould Infection

Sites in Birmingham +5 more locations

Sponsor: Elion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07215273·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome

for Alport Syndrome

Sites in Birmingham +5 more locations

Sponsor: Bayer

Sex: All·Age: 18 - 45

Code: NCT07211685·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

Sites in Dothan +2 more locations

Sponsor: AbbVie

Sex: All·Age: 40+

Code: NCT07230288·Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients

for Knee Osteoarthritis

Sites in Birmingham +7 more locations

Sponsor: Doron Therapeutics Inc.

Sex: All·Age: 40 - 80

Code: NCT07219771·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital

for COPD

Sites in Birmingham +3 more locations

Sponsor: Fisher and Paykel Healthcare

Sex: All·Age: 22+

Code: NCT07222410·Recruiting·Listed Oct 2025

Apply to this trial

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Drug: Tulmimetostat

Sites in Birmingham +7 more locations

Sponsor: Novartis Pharmaceuticals

Sex: Male·Age: 18+

Code: NCT07190300·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

for Heterozygous Familial Hypercholesterolemia

Sites in Dothan +7 more locations

Sponsor: Verve Therapeutics, Inc.

Sex: All·Age: 18 - 70

Code: NCT06164730·Phase 1·Recruiting·Listed Dec 2023

Apply to this trial

Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)

for Lung Neoplasm Malignant

Sites in Daphne +7 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06788912·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

for Sickle Cell Disease

Sites in Birmingham +6 more locations

Sponsor: Disc Medicine, Inc

Sex: All·Age: 18+

Code: NCT07187973·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty

for Pain

Sites in Daphne +4 more locations

Sponsor: Synaptrix, Inc.

Sex: All·Age: 21+

Code: NCT07191067·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

for Multiple Myeloma

Sites in Mobile +6 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT06980480·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

for Advanced Solid Tumors

Sites in Birmingham +6 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06818643·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration Technology

for Urolithiasis

Sites in Birmingham +4 more locations

Sponsor: Calyxo, Inc.

Sex: All·Age: 18+

Code: NCT07101809·Recruiting·Listed Aug 2025

Apply to this trial

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

for Atopic Dermatitis

Sites in Birmingham +8 more locations

Sponsor: Pfizer

Sex: All·Age: 2 - 11

Code: NCT06807281·Phase 3·Recruiting·Listed Feb 2025

Apply to this trial

TLN-372 in Advanced KRAS Mutant Solid Tumors

for KRAS Mutant Solid Tumors

Sites in Birmingham +5 more locations

Sponsor: Treeline Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07204340·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

for Familial Partial Lipodystrophy

Sites in Birmingham +6 more locations

Sponsor: Chiesi Farmaceutici S.p.A.

Sex: All·Age: 13+

Code: NCT06679270·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

for Metastatic Non-Squamous Non-Small Cell Lung Cancer

Sites in Birmingham +6 more locations

Sponsor: CatalYm GmbH

Sex: All·Age: 18+

Code: NCT07098988·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

for Sickle Cell Disease

Sites in Birmingham +5 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 12 - 55·Accepts healthy volunteers

Code: NCT06546670·Phase 1, Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

for Non-cystic Fibrosis Bronchiectasis

Sites in Birmingham +4 more locations

Sponsor: Genentech, Inc.

Sex: All·Age: 18+

Code: NCT06603246·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

Radiation Free Study

for Aortic Aneurysm

Sites in Birmingham +4 more locations

Sponsor: Philips Clinical & Medical Affairs Global

Sex: All·Age: 18+

Code: NCT06549348·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

for Locally Advanced Solid Tumors

Drug: Atezolizumab

Sites in Birmingham +5 more locations

Sponsor: Genentech, Inc.

Sex: All·Age: 18+

Code: NCT06031441·Phase 1·Recruiting·Listed Sep 2023

Apply to this trial

Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age

for Catheter-Related Infections

Sites in Birmingham +5 more locations

Sponsor: CorMedix

Sex: All·Age: Up to 17

Code: NCT06714864·Phase 4·Recruiting·Listed Dec 2024

Apply to this trial

A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer

for Hepatocellular Carcinoma

Sites in Dothan +1 more location

Sponsor: Bayer

Sex: All·Age: 18+

Code: NCT06764316·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients

for Pediatric Chronic Inflammatory Demyelinating Polyneuropathy

Sites in Birmingham +5 more locations

Sponsor: Octapharma

Sex: All·Age: 2 - 17

Code: NCT04929236·Phase 3·Recruiting·Listed Jun 2021

Apply to this trial

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

for Multiple Myeloma

Drug: Elranatamab

Sites in Birmingham +3 more locations

Sponsor: Celgene

Sex: All·Age: 18+

Code: NCT06988488·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

for Sickle Cell Disease

Sites in Birmingham +1 more location

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 6 Months - 100

Code: NCT04657822·Phase 4·Recruiting·Listed Dec 2020

Apply to this trial

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

for Pancreatic Ductal Adenocarcinoma

Sites in Birmingham +8 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 100

Code: NCT06562192·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

A Study of Patients With Fabry Disease (US Specific)

for Fabry Disease

Sites in Birmingham +7 more locations

Sponsor: Amicus Therapeutics

Sex: All·Age: 18+

Code: NCT06906367·Recruiting·Listed Apr 2025

Apply to this trial

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

for Castration-Resistant Prostate Cancer (CRPC)

Sites in Dothan +3 more locations

Sponsor: Radiopharm Theranostics, Ltd

Sex: All·Age: 18+

Code: NCT07189871·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

for Ovarian Cancer

Sites in Birmingham +6 more locations

Sponsor: Tubulis GmbH

Sex: All·Age: 18+

Code: NCT06303505·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

Effect of Ensifentrine on Sputum Markers of Inflammation in COPD

for COPD

Sites in Birmingham +2 more locations

Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Sex: All·Age: 40 - 80

Code: NCT05270525·Phase 2·Recruiting·Listed Mar 2022

Apply to this trial

Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS)

for Bronchiectasis Adult

Sites in Birmingham +2 more locations

Sponsor: Synchrony-Medical, Ltd

Sex: All·Age: 21+

Code: NCT07135284·Recruiting·Listed Aug 2025

Apply to this trial

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

for Glomerulonephritis, IGA

Drug: Iptacopan

Sites in Birmingham +8 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 99

Code: NCT06797518·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment

for Non-small Cell Lung Cancer

Drug: Pumitamig

Sites in Birmingham +3 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT06841055·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Shoulder Innovations Clinical Data Registry

for Shoulder Arthroplasty

Sites in Birmingham +7 more locations

Sponsor: Shoulder Innovations

Sex: All·Age: 18+

Code: NCT06754150·Recruiting·Listed Dec 2024

Apply to this trial

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

for Small Cell Lung Cancer

Sites in Birmingham +2 more locations

Sponsor: Advenchen Pharmaceuticals, LLC.

Sex: All·Age: 18+

Code: NCT05363280·Phase 2·Recruiting·Listed May 2022

Apply to this trial

A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)

for Alpha 1-Antitrypsin Deficiency

Sites in Birmingham +2 more locations

Sponsor: Beam Therapeutics Inc.

Sex: All·Age: 18 - 70

Code: NCT06389877·Phase 1, Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

for Hypothalamic Obesity

Sites in Birmingham +7 more locations

Sponsor: Rhythm Pharmaceuticals, Inc.

Sex: All·Age: 4+

Code: NCT06760546·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial